Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06376604 · ClinicalTrials.gov registry record · NA
Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies
A NA study of Chemotherapy Effect and Cancer - Ovarian, sponsored by L-Nutra.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT06376604: Recruiting NA study of Chemotherapy Effect and Cancer - Ovarian, sponsored by L-Nutra.
NCT06376604 is a NA study of Chemotherapy Effect and Cancer - Ovarian that is actively recruiting participants, run by L-Nutra. The registered enrollment target is 30 participants, below the 100-participant average among 7 other Chemotherapy Effect trials with a reported enrollment target (70% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06376604, a NA study of Chemotherapy Effect and Cancer - Ovarian, is actively recruiting participants, sponsored by L-Nutra.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study evaluates how lifestyle modifications that may be made to manage chemotherapy side effects in patients with gynecologic malignancies.
Conditions Studied
Interventions
- DRUG Chemotherapy
- OTHER Fasting Mimicking Diet
Study Locations (1)
Tennessee
- The University of Tennessee Medical Center - Knoxville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-09-08 |
| Est. Completion | 2025-12-30 |
| Phase | NA |
What NCT06376604 shows while recruiting
NCT06376604 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 100-participant average among 7 other Chemotherapy Effect trials with a reported enrollment target (70% lower).
The record links to 4 conditions, with Chemotherapy Effect appearing as the primary indexed condition, and to 2 interventions - of which Chemotherapy is the first listed.
NCT06376604 reports a single indexed study location in Tennessee.
Frequently Asked Questions
What is clinical trial NCT06376604 about?
NCT06376604 is a clinical study titled "Fasting Mimicking Diet in Chemotherapy of Gynecologic Malignancies". This study evaluates how lifestyle modifications that may be made to manage chemotherapy side effects in patients with gynecologic malignancies.
What is the current status of trial NCT06376604?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2021-09-08. Estimated completion is 2025-12-30.
What conditions does trial NCT06376604 study?
This clinical trial studies the following conditions: Chemotherapy Effect, Cancer - Ovarian, Fasting, Intermittent, Calorie Deficiency.
What interventions are being tested in trial NCT06376604?
The interventions under investigation include: Chemotherapy (DRUG), Fasting Mimicking Diet (OTHER).
Who is sponsoring clinical trial NCT06376604?
This trial is sponsored by L-Nutra, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06376604 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chemotherapy Effect
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improve Cancer-related Cognitive Impairment
RECRUITING · NA
-
Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy
RECRUITING · NA
-
Massage Impact on Sleep in Pediatric Oncology
RECRUITING · NA
-
Evaluation of a Mobile App to Promote Social Support for Oncology Patients
COMPLETED · NA
-
FOcus on Reducing Dose-limiting Toxicities in Colon Cancer With Resistance Exercise Study
COMPLETED · NA
-
Cognitive Impairment in Colorectal Cancer Patients Receiving Cytotoxic Chemotherapy
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI